Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers

Award Notice Posted

Solicitation number
N01CN5500347
Agency
Awarded
to The Institute For Cancer Research
Set-aside
No set-aside

Opportunity facts

Contract number
HHSN261201500032I-HHSN26100001 Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

Multiple Award IDIQ to the following contractors:

HHSN261201500032I, The Research Institute of Fox Chase Cancer Center
HHSN261201500041I, SRI International
HHSN261201500042I, IIT Research Institute
HHSN261201500018I, University of Texas MD Anderson Cancer Center
HHSN261201500036I, University of Alabama at Birmingham
HHSN261201500037I, Medical College of Wisconsin
HHSN261201500038I, University of Oklahoma Health Sciences Center
HHSN261201500039I, Weill Medical College of Cornell University

Notice history

Notice Type Posted
This notice Latest Award Notice
Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity